BlackRock Fund Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

BlackRock Fund Advisors’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$90M	Buy	5,983,161 +725,141	+14%	+$9.58M	0.02%	1278
2016 Q3	$61.5M	Buy	5,258,020 +335,064	+7%	+$3.94M	0.01%	1431
2016 Q2	$53.2M	Buy	4,922,956 +210,607	+4%	+$2.17M	0.01%	1449
2016 Q1	$43.5M	Buy	4,712,349 +39,777	+0.9%	+$428K	0.01%	1538
2015 Q4	$69.3M	Buy	4,672,572 +8,432	+0.2%	+$141K	0.02%	1242
2015 Q3	$76.5M	Buy	4,664,140 +310,048	+7%	+$6.35M	0.02%	1117
2015 Q2	$99.3M	Buy	4,354,092 +776,355	+22%	+$15.5M	0.02%	998
2015 Q1	$54.4M	Buy	3,577,737 +310,609	+10%	+$4.04M	0.01%	1454
2014 Q4	$39.3M	Buy	3,267,128 +271,066	+9%	+$3.1M	0.01%	1623
2014 Q3	$34M	Sell	2,996,062 -16,533	-0.5%	-$189K	0.01%	1609
2014 Q2	$36.4M	Sell	3,012,595 -176,417	-6%	-$2.08M	0.01%	1619
2014 Q1	$37.2M	Buy	3,189,012 +63,477	+2%	+$1.07M	0.01%	1601
2013 Q4	$55.3M	Buy	3,125,535 +89,313	+3%	+$1.5M	0.02%	1328
2013 Q3	$43.7M	Buy	3,036,222 +362,600	+14%	+$5.55M	0.01%	1440
2013 Q2	$40.3M	Buy	+2,673,622	New	+$35.3M	0.01%	1384

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BlackRock Fund Advisors's MNTA Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Momenta Pharmaceuticals, Inc. (MNTA) stake by 14% in Q4 2016, buying an estimated $9.58M and bringing the position to 5,983,161 shares worth $90M. The position accounts for 0.02% of the portfolio, ranked #1278.

BlackRock Fund Advisors first reported a position in MNTA in Q2 2013 and has held it in 15 quarters since. The position peaked at $99.3M in Q2 2015. 160 funds tracked by Wall St. Rank hold MNTA as of Q4 2016.

BlackRock Fund Advisors held 5,983,161 shares of Momenta Pharmaceuticals, Inc. worth $90M as of Q4 2016.
BlackRock Fund Advisors bought 725,141 Momenta Pharmaceuticals, Inc. shares in Q4 2016, an estimated $9.58M.
Momenta Pharmaceuticals, Inc. made up 0.02% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1278 holding.
BlackRock Fund Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Fund Advisors's Momenta Pharmaceuticals, Inc. position peaked at $99.3M in Q2 2015.
160 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.